Misa Azuma

Misa Azuma advises and represents clients on capital markets and regulatory compliance, with a particular focus on general corporate matters.

Misa represents issuers and underwriters on global offerings, SEC registrations, and securities law issues, including those related to business combinations. In addition to her corporate expertise, Misa has experience in litigation, investigations and anti-corruption matters.

Prior to joining Mayer Brown, Misa advised:

• Ajinomoto Co. Inc. in its acquisition of Forge Biologics Holdings LLC, through a reverse triangular merger transaction valued at approximately $554 million.
• Sawai Pharmaceutical Co., Ltd. regarding a registration with the U.S. Securities and Exchange Commission on Form F-4 in connection with the sole share transfer to establish Sawai Group Holdings Co., Ltd. as a holding company.
• Toyota Motor Corporation in a $2.75 billion SEC-registered offering of sustainability bonds.
• One of the major Mitsubishi group companies and its affiliates in a potential FCPA violation matter and internal investigation.
• One of the major Mitsubishi group companies and its Japanese subsidiary in an employment litigation matter in the U.S.

• Georgetown University Law Center, LLM
• Keio University, LLB

• New York

• English
• Japanese